HIMSS23

At HIMSS23, panelists explained how digital therapeutics must appeal to all healthcare stakeholders – including clinicians, patients, hospitals and payers – to work well in clinical settings.

At HIMSS23, panelists discussed how genomics could improve patient care and the challenges to implementing genetic testing programs.

At HIMSS23, Holly Maloney, managing director of General Catalyst, discussed the promise and challenge of using artificial intelligence in healthcare.

At HIMSS23, panelists discussed health systems' financial challenges as labor costs rise and the population ages.

At HIMSS23, panelists discussed their investment strategies and the types of companies that are more likely to prosper in today's funding environment.

At HIMSS23, Jodi Daniel, managing director of Crowell Health Solutions, discussed the evolving policy landscape for telehealth, remote patient monitoring and other digital health technologies as the public health emergency comes to a close.

During Venture Connect at HIMSS23, panelists discussed the future of digital therapeutics.

At a HIMSS23 talk, panelists discussed how technology may improve health equity if the right steps are taken during the development process.

Mount Sinai Health System's Darryl Hollar and Cathleen Mathew discuss the importance of technology choice, clear communication and data reliability when implementing a remote patient monitoring program.

Julie Rish, associate chief improvement officer of design at the Cleveland Clinic, explains how human-centered design could help healthcare organizations create digital tools that ensure the end user — the patient — is kept at the center.